Fischbach receives New Innovator Award

Michael Fischbach, PhD, is the recipient of a 2010 NIH Director’s New Innovator Award from the National Institutes of Health. Fischbach is a faculty member in the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine. The award, which funds innovative science that has the potential for high impact, will support Fischbach’s goal of identifying and characterizing small molecules from the human microbiome—the collection of microorganisms that exist on and in the human body. “These molecules will not only lead to a greater understanding of the connection between the human microbiome and human disease, it will also lay the groundwork for engineering new probiotic bacterial strains (like the bacteria found in yogurt) that could promote human health and help fight diseases like Crohn’s disease and obesity,” he explains. Fischbach is among 52 award recipients for 2010, including three others from UCSF. The 2010 award winners were announced on September 30, 2010 by the NIH.


UCSF Tops California Universities with Four NIH Director’s New Innovator Awards

NIH Director’s New Innovator Award


School of Pharmacy, Department of Bioengineering and Therapeutic Sciences, PharmD Degree Program, BMI, QBC, CCB, PSPG, Bioinformatics

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.